IOVANCE BIOTHERAPEUTICS, INC. Class of Warrant or Right, Outstanding
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Class of Warrant or Right, Outstanding of 6.95 million shares as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2016-08-09
- 2016-06-30: Class of Warrant or Right, Outstanding 6.95M shares.
- 2016-03-31: Class of Warrant or Right, Outstanding 7.20M shares.
- 2015-12-31: Class of Warrant or Right, Outstanding 7.20M shares.
- 2015-06-30: Class of Warrant or Right, Outstanding 11.43M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2016-06-30 | 6.95M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 7.20M shares 10-Q · filed 2016-05-09 |
| 2015-12-31 | 7.20M shares 10-K · filed 2016-03-11 |
| 2015-06-30 | 11.43M shares 10-Q · filed 2016-08-09 |
| 2014-12-31 | 11.08M shares 10-K · filed 2016-03-11 |
| 2013-12-31 | 12.37M shares 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |